Free tool
FAERS Monitor: Technetium Tc 99m Albumin Aggregated Kit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 017881 or its brand name (Technetium Tc 99m Albumin Aggregated Kit, Technetium Tc-99m Albumin Aggregated Kit). Reports on generic versions are filed under their own applications.
Reports
30
Serious
5
17% of reports
Hospitalization
1
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective17
- off label use3
- product preparation issue3
- pruritus3
- radioisotope uptake increased3
- accidental underdose2
- dyspnoea2
- product distribution issue2
- product preparation error2
- rash2
- urticaria2
- anaphylactic reaction1
- anaphylactoid reaction1
- cardiac arrest1
- cough1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 4 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,129 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| radioisotope uptake increasedSignal | 3 | 51351.5 | 16816.7 | 99,684 |
| product preparation issueSignal | 3 | 320.8 | 109.6 | 663 |
| anaphylactoid reaction | 1 | 170.4 | 24.8 | 42 |
| product distribution issue | 2 | 151.2 | 39.6 | 167 |
| accidental underdose | 2 | 97.4 | 25.5 | 107 |
| product preparation error | 2 | 68.3 | 17.9 | 74 |
| anaphylactic reaction | 1 | 12.7 | 1.8 | 2 |
| drug ineffectiveSignal | 17 | 9.0 | 6.6 | 121 |
| cardiac arrest | 1 | 8.5 | 1.2 | 1 |
| urticaria | 2 | 8.4 | 2.2 | 7 |
| pruritusSignal | 3 | 5.5 | 1.9 | 7 |
| rash | 2 | 3.2 | 0.8 | 1 |
| cough | 1 | 2.5 | 0.4 | 0 |
| dyspnoea | 2 | 2.5 | 0.6 | 1 |
| off label use | 3 | 2.4 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.